Voglibose Tablets Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 0.2 mg, 0.3 mg

Reference Brands: Volix®, Vocarb®, Voglimet®, Basen®(EU/Asia)

Category: Diabetes

Voglibose works by inhibiting intestinal alpha-glucosidase enzymes, delaying carbohydrate digestion and glucose absorption. This helps control post-meal blood sugar spikes. It is particularly beneficial for managing postprandial hyperglycemia in type 2 diabetes, improving glycemic control without causing significant hypoglycemia when used as monotherapy. Voglibose Tablets is available in Tablets and strengths such as 0.2 mg, 0.3 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Voglibose Tablets is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Voglibose Tablets can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description: Voglibose is an oral alpha-glucosidase inhibitor used primarily for the management of postprandial blood glucose levels in type 2 diabetes mellitus. It is not FDA-approved in the United States and thus not commercially available there. In the European Union, Voglibose is not broadly authorized but may be marketed in specific regions under national licenses. The drug is extensively approved and utilized in countries like India and Japan, where it is sold under various brand names. It is often used alone or in combination with other antidiabetic agents. Regulatory approvals focus on its efficacy in delaying glucose absorption.